West G. L., Drisdelle B. L., Konishi K., Jackson J., Jolicoeur P., Bohbot V. (2015). Habitual action video game playing is associated with caudate nucleus-dependent navigational strategies, Proc Biol Sci, 282(1808), 20142952. Find out more.

Wheeler A. L., Wessa M., Szeszko P. R., Foussias G., Chakravarty M., Lerch J. P., DeRosse P., Remington G., Mulsant B. H., Linke J., Malhotra A. K., Voineskos A. N. (2015). Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis, JAMA Psychiatry, 72(5), 446-55. Find out more.

Xiao Y., Fonov V., Beriault S., Subaie F. A., Chakravarty M., Sadikot A. F., Pike G. B., Collins D. L. (2015). Multi-contrast unbiased MRI atlas of a Parkinson's disease population, Int J Comput Assist Radiol Surg, 10(3), 329-341. Find out more.

Yushkevich P. A., Amaral R. S., Augustinack J. C., Bender A. R., Bernstein J. D., Boccardi M., Bocchetta M., Burggren A. C., Carr V. A., Chakravarty M., Chetelat G., Daugherty A. M., Davachi L., Ding S. L., Ekstrom A., Geerlings M. I., Hassan A., Huang Y., Iglesias J. E., La Joie R., Kerchner G. A., LaRocque K. F., Libby L. A., Malykhin N., Mueller S. G., Olsen R. K., Palombo D. J., Parekh M. B., Pluta J. B., Preston A. R., Pruessner J., Ranganath C., Raz N., Schlichting M. L., Schoemaker D., Singh S., Stark C. E., Suthana N., Tompary A., Turowski M. M., Van Leemput K., Wagner A. D., Wang L., Winterburn J. L., Wisse L. E., Yassa M. A., Zeineh M. M. (2015). Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol, Neuroimage, 111, 526-41. Find out more.

Adamantidis A., Zhang F., de Lecea L., Deisseroth K. (2014). Establishing a fiber-optic-based optical neural interface, Cold Spring Harb Protoc, 2014(8), 839-44. Find out more.

Adamantidis A., Zhang F., de Lecea L., Deisseroth K. (2014). Optogenetics: opsins and optical interfaces in neuroscience, Cold Spring Harb Protoc, 2014(8), 815-22. Find out more.

Bastianetto S., Menard C., Quirion R. (2014). Neuroprotective action of resveratrol, Biochim Biophys Acta. Find out more.

Belleville S., Gauthier S., Lepage E., Kergoat M. J., Gilbert B. (2014). Predicting decline in mild cognitive impairment: a prospective cognitive study, Neuropsychology, 28(4), 643-52. Find out more.

Boccardi M., Bocchetta M., Apostolova L. G., Barnes J., Bartzokis G., Corbetta G., DeCarli C., deToledo-Morrell L., Firbank M., Ganzola R., Gerritsen L., Henneman W., Killiany R. J., Malykhin N., Pasqualetti P., Pruessner J., Redolfi A., Robitaille N., Soininen H., Tolomeo D., Wang L., Watson C., Wolf H., Duvernoy H., Duchesne S., Jack C. R., Frisoni G. B. (2014). Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance, Alzheimers Dement. Find out more.

Bocchetta M., Boccardi M., Ganzola R., Apostolova L. G., Preboske G., Wolf D., Ferrari C., Pasqualetti P., Robitaille N., Duchesne S., Jack C. R., Frisoni G. B., Pruessner J. (2014). Harmonized benchmark labels of the hippocampus on magnetic resonance: The EADC-ADNI project, Alzheimers Dement. Find out more.

Breitner J. (2014). Mild cognitive impairment and progression to dementia: new findings, Neurology, 82(4), e34-5. Find out more.

Breitner J. (2014). What should we do if we were wrong and Alzheimer was right?, Int Psychogeriatr, 1-4. Find out more.

Breitner J. (2014). Observations on DSM-5 Mild Neurocognitive Disorder vs. its predecessor, Mild Cognitive Impairment, Acta Psychiatr Scand. Find out more.

Chuang Y. F., Breitner J., Chiu Y. L., Khachaturian A., Hayden K., Corcoran C., Tschanz J., Norton M., Munger R., Welsh-Bohmer K., Zandi P. P., Cache County Investigators (2014). Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study, Neurobiol Aging, 35(11), 2429-35. Find out more.

Cyr M., Parent M. J., Mechawar N., Rosa-Neto P., Soucy J. P., Aliaga A., Kostikov A., Maclaren D. A., Clark S. D., Bedard M. A. (2014). PET imaging with [(1)(8)F]fluoroethoxybenzovesamicol ([(1)(8)F]FEOBV) following selective lesion of cholinergic pedunculopontine tegmental neurons in rat, Nucl Med Biol, 41(1), 96-101. Find out more.

Cyr M., Parent M. J., Mechawar N., Rosa-Neto P., Soucy J. P., Clark S. D., Aghourian M., Bedard M. A. (2014). Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and in vivo PET imaging with [F]fluoroethoxybenzovesamicol, Behav Brain Res, 278C, 107-114. Find out more.

De Schutter J. W., Park J., Leung C. Y., Gormley P., Lin Y. S., Hu Z., Berghuis A. M., Poirier J., Tsantrizos Y. S. (2014). Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases, J Med Chem, 57(13), 5764-76. Find out more.

Dedovic K., Duchesne A., Engert V., Lue S. D., Andrews J., Efanov S. I., Beaudry T., Pruessner J. (2014). Psychological, endocrine and neural responses to social evaluation in subclinical depression, Soc Cogn Affect Neurosci, 9(10), 1632-44. Find out more.

Dubois B., Feldman H. H., Jacova C., Hampel H., Molinuevo J. L., Blennow K., DeKosky S. T., Gauthier S., Selkoe D., Bateman R., Cappa S., Crutch S., Engelborghs S., Frisoni G. B., Fox N. C., Galasko D., Habert M. O., Jicha G. A., Nordberg A., Pasquier F., Rabinovici G., Robert P., Rowe C., Salloway S., Sarazin M., Epelbaum S., de Souza L. C., Vellas B., Visser P. J., Schneider L., Stern Y., Scheltens P., Cummings J. L. (2014). Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, Lancet Neurol, 13(6), 614-29. Find out more.

Duerden E. G., Card D., Roberts S. W., Mak-Fan K. M., Chakravarty M., Lerch J. P., Taylor M. J. (2014). Self-injurious behaviours are associated with alterations in the somatosensory system in children with autism spectrum disorder, Brain Struct Funct, 219(4), 1251-61. Find out more.